Our politicians and health technology institutions invite this comparison, and the obvious question, given that the latter consistently invokes opportunity cost to justify rejecting funding for innovative medicines. Opportunity cost is not just an economic consideration. It is a moral and ethical question when the powerful are preferenced over patients. …
Opportunity cost is a moral and ethical question when it involves travel, tickets, or treating sick children
December 11, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Guilt over this enduring failure is the correct response
September 9, 2026 - -
Poweroos chase world title in Argentina with new backing from Biogen
September 9, 2026 - - Latest News -
What will AI be capable of in two months? We don't know, and that's the point
September 9, 2026 - - Latest News -
'You can't fix a broken system by tinkering with parts of it'
September 9, 2026 - - Latest News -
A review recommendation that should be reconsidered because of time
September 8, 2026 - - Latest News -
The forgotten patients living in the long shadow of rare cancer
September 8, 2026 - - Latest News -
Pharmacists could save women millions and cut GP queues, new analysis shows
September 8, 2026 - - Latest News